E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/15/2005 in the Prospect News Convertibles Daily.

New Issue: Goldman Sachs prices $20 million 6.8% trigger notes exchangeable for Merck

New York, Feb. 15 - The Goldman Sachs Group Inc. priced $20 million of one-year 6.8% trigger notes mandatorily exchangeable for the common stock of Merck & Co. Inc., according to a 424B3 filing with the Securities and Exchange Commission.

Issuer:Goldman Sachs Group Inc.
Underlying stock:Merck & Co. Inc.
Issue:Trigger mandatory exchangeable medium-term notes
Amount:$20.000 million
Maturity:Feb. 17, 2006
Coupon:6.8%, payable quarterly
Price:Par of $28.733
Payout at maturity:1 share of Merck stock per $28.733 principal amount, capped at $31.6063 or 110% above initial stock price of $28.733, in cash or stock at Goldman's option; if market price does not fall below threshold price, then payout has a floor of par, in cash or stock at Goldman's option
Threshold price:$22.412, 78% of initial price of $28.733
Call:Non-callable
Pricing date:Feb. 9
Settlement date:Feb. 16

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.